文献速递泌尿生殖腹部CTMR

低级别嗜酸细胞肿瘤:影像学与临床特征综述

Low-grade oncocytic tumor: a review of radiologic and clinical features.
PubMed 文献 · Abdom Radiol (NY) · 2024-02-19

该回顾性研究报告10例低级别嗜酸细胞肿瘤(LOT)的影像与临床行为:均为单发、边界清楚、含实性成分的肾脏肿块,增强程度与邻近肾实质相当或几乎相当,多呈不均匀强化,随访未见淋巴结转移、静脉侵犯或转移。作者认为成人肾脏明显且通常不均匀强化的实性肿块鉴别诊断中可考虑LOT。

要点

  • LOT表现为单发、边界清楚、含实性成分的肾脏肿块,增强程度与邻近肾实质相当或几乎相当。
  • 所有肿瘤中除1例外均呈不均匀强化,未见淋巴结肿大、静脉侵犯或转移。
  • 5例接受主动监测者影像随访中位16.7个月,年均增大0.4 cm。

核心结论

  • LOT是近年描述的肾脏病理实体,在成人肾脏明显且通常不均匀强化的实性肿块鉴别诊断中可考虑。

研究设计与样本

  • 经IRB批准、符合HIPPA的回顾性研究,检索本院病理数据库,最终纳入10例患者的10个肿瘤,中位直径2.3 cm(范围0.7-5.1),中位年龄68岁(范围53-91),其中女性6例。

关键影像表现/征象

  • 所有肿瘤均表现为单发、边界清楚、含实性成分的肿块。
  • 所有肿瘤强化程度与邻近肾实质相当或几乎相当。
  • 除1例外所有肿瘤呈不均匀强化。
  • 初诊及临床随访(中位22.2个月,范围3.4-71.6)均无淋巴结肿大、静脉侵犯或转移性疾病。

临床应用与阅片要点

  • 作者认为,成人肾脏明显且通常不均匀强化的实性肿块在鉴别诊断中可考虑LOT。
  • 5例接受主动监测的肿瘤在影像随访(中位16.7个月,范围8.9-25.4)中平均增大0.4 cm/年。

局限性

  • 原文为回顾性研究。
  • 病理数据库检索得到14个肿瘤,其中3例无影像学图像、1例病理复阅后不符合诊断标准而被排除,最终分析10个肿瘤。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: The 2022 World Health Organization classification of renal neoplasia expanded the spectrum of oncocytic neoplasms to encompass newly established and emerging entities; one of the latter is the low-grade oncocytic tumor (LOT). This study reports the radiologic appearance and clinical behavior of LOT.

METHODS: In this IRB-approved, HIPPA-compliant retrospective study, our institution's pathology database was searched for low-grade oncocytic tumors or neoplasms. Patient age, gender, and comorbidities were obtained from a review of electronic medical records, and imaging characteristics of the tumors were assessed through an imaging platform.

RESULTS: The pathology database search yielded 14 tumors in 14 patients. Four patients were excluded, as radiologic images were not available in three, and one did not fulfill diagnostic criteria after pathology re-review. The resulting cohort consisted of 10 tumors (median diameter 2.3 cm, range 0.7-5.1) in 10 patients (median age 68 years, range 53-91, six women). All tumors presented as a solitary, well-circumscribed, mass with solid components. All enhanced as much or almost as much as adjacent renal parenchyma; all but one enhanced heterogeneously. None had lymphadenopathy, venous invasion, or metastatic disease at presentation or at clinical follow-up (median, 22.2 months, range 3.4-71.6). Among five tumors undergoing active surveillance, mean increase in size was 0.4 cm/year at imaging follow-up (median 16.7 months, range 8.9-25.4).

CONCLUSION: LOT, a recently described pathologic entity in the kidney, can be considered in the differential diagnosis of an avidly and typically heterogeneously enhancing solid renal mass in an adult patient.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Chai JL, Siegmund SE, Hirsch MS, et al. Low-grade oncocytic tumor: a review of radiologic and clinical features. Abdom Radiol (NY). 2024. PMID: 38372764. doi:10.1007/s00261-023-04167-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。